ClinConnect ClinConnect Logo
Search / Trial NCT01927510

TEAM: A Trial of Early Activity and Mobility in ICU

Launched by AUSTRALIAN AND NEW ZEALAND INTENSIVE CARE RESEARCH CENTRE · Aug 20, 2013

Trial Information

Current as of May 20, 2025

Completed

Keywords

Early Mobilization, Rehabilitation, Intensive Care

ClinConnect Summary

Patients who are admitted and treated in the intensive care unit (ICU) generally have potentially reversible critical illness. While many patients survive, substantial proportions of patients fail to recover completely and do not return to their pre-morbid level of health. Critically ill patients receive mechanical ventilation, as a lifesaving intervention, but this is routinely managed with deep sedation and immobility, which results in prolonged periods of bed rest. Severe muscle weakness, termed ICUAW, is common and associated with prolonged duration of mechanical ventilation and hospita...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults \> or + to 18 years old admitted to the ICU
  • Invasively ventilated and expected to be ventilated the day after tomorrow
  • Written informed consent from person responsible/ net of kin (or consent as per individual HREC if delayed or telephone consent is acceptable)
  • Exclusion Criteria:
  • 1. INSTABILITY A. Cardiovascular
  • Unresolved rhythm disturbance with any bradycardia requiring pharmacological support
  • Any tachycardia with ventricular rate \> 150 beats/min
  • Lactacte \> 4.0 due to inadequate tissue perfusion
  • Any external mechanical cardiovascular support (eg. VA ECMO or intra-aortic balloon pump)
  • Norad \> 0.2mcg/kg/min (or unit equivalent) or any dose of norad between 0.1 and 0.2mcg/kg/min with more than a 25% increase in last 6 hours
  • Cardiac index \< 2.0L/min/m\^2
  • B. Respiratory
  • FiO2 \> 0.6
  • PEEP \> 15
  • Requirement for hypoxaemic rescue interventions eg. NO, prone, ECMO, prostacyclin, HFOV
  • RR \> 45
  • 2. Proven or suspected actue brain injury such as stroke, sub-arachnoid haemorrhage, encephalitis, or moderate to severe traumatic brain injury
  • 3. Proven or suspected actue spinal cord injury
  • 4. Proven or suspected Guillain-Barre Syndrome
  • 5. Second or subsequent ICU admission during a single hospital admission
  • 6. Unable to follow simple verbal commands in English
  • 7. Death inevitable and imminent
  • 8. Inability to walk without assistance of another person prior to onset of acute illness necessitating ICU admission
  • 9. Cognitive impairment prior to current acute illness
  • 10. Agitation which int he opinion of the treating clinician precludes safe implementation of EGDM
  • 11. Written rest in bed orders due to documented injury or process the precludes mobilisation such as suspected or proven instability of spine or pelvis
  • 12. In the opinion of the treating clinician it is unsafe to commence EGDM
  • 13. Has met all the inclusion criteria with no concomitant exclusion criteria for a period of more than 48 hours

About Australian And New Zealand Intensive Care Research Centre

The Australian and New Zealand Intensive Care Research Centre (ANZIC-RC) is a leading research organization dedicated to improving outcomes in critically ill patients through innovative clinical trials and research initiatives. Based at Monash University, the Centre fosters collaborative partnerships among clinicians, researchers, and institutions across Australia and New Zealand. Its focus on evidence-based practice and translational research aims to enhance the quality of intensive care, drive advancements in treatment protocols, and ultimately improve patient care in the intensive care unit (ICU) setting. ANZIC-RC is committed to addressing key challenges in critical care medicine, ensuring that findings from its trials contribute to better health outcomes and inform clinical guidelines globally.

Locations

Fremantle, Western Australia, Australia

Melbourne, , Australia

Newtown, Wellington, New Zealand

Grafton, Auckland, New Zealand

Heidelberg, Victoria, Australia

Patients applied

0 patients applied

Trial Officials

Carol L Hodgson, PhD

Study Chair

Australian and New Zealand Intensive Care Research Centre

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials